미국주식 MNMD 에 대한 정보. MindMed 상장 나스닥 IPO

MindMed is a psychedelic medicine biotech company that studies how shrooms, LSD, and even MDMA and DMT can help treat depression. Honestly, I already confirmed their studies to be true in college. Anyways, MindMed has been trading OTC in like Canada's market or something (I guess there are companies that exist outside the USA) so only brokers that allow OTC trading let you buy it. As of today though not anymore! They announced that they will begin trading on the Nasdaq on Tuesday, April 27, 2021 under the symbol: MNMD. Reasons I invested: 1 To get in before Nasdaq listing (not too late to..........

원문링크 : 미국주식 MNMD 에 대한 정보. MindMed 상장 나스닥 IPO